[Form 4] AMN HEALTHCARE SERVICES INC Insider Trading Activity

Rhea-AI Filing Summary

AMN Healthcare Services executive Mark Christopher Hagan, Chief Information and Digital officer, reported multiple equity compensation transactions on January 15, 2026. Several blocks of Restricted Stock Units (RSUs) vested and were converted into common stock, including 1,433, 2,248, and 6,632 shares of AMN common stock. To cover taxes, the company withheld 591, 926, and 2,622 shares at a price of $19.55 per share.

On the same date, Hagan received a new grant of 36,828 RSUs under the AMN Healthcare 2025 Equity Plan, each representing a right to one share of common stock. After these transactions, he directly owned 44,873 shares of AMN common stock and held 73,656 RSUs. The RSUs granted on January 15 of 2023, 2024, 2025, and 2026 all vest in three annual tranches tied to continued service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hagan Mark Christopher

(Last) (First) (Middle)

12400 HIGH BLUFF DRIVE, SUITE 500

(Street)

SAN DIEGO CA 92130

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AMN HEALTHCARE SERVICES INC [ AMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Information and Digital

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/15/2026		M(1)		1,433	A	$0	40,132	D
Common Stock	01/15/2026		F(2)		591	D	$19.55	39,541	D
Common Stock	01/15/2026		M(1)		2,248	A	$0	41,789	D
Common Stock	01/15/2026		F(2)		926	D	$19.55	40,863	D
Common Stock	01/15/2026		M(1)		6,632	A	$0	47,495	D
Common Stock	01/15/2026		F(2)		2,622	D	$19.55	44,873	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(3)	01/15/2026		M			1,433	(4)	(5)	Common Stock	1,433	$0	0	D
Restricted Stock Units	(3)	01/15/2026		M			2,248	(6)	(5)	Common Stock	2,248	$0	2,317	D
Restricted Stock Units	(3)	01/15/2026		M			6,632	(7)	(5)	Common Stock	6,632	$0	13,467	D
Restricted Stock Units	(8)	01/15/2026		A		36,828		(9)	(5)	Common Stock	36,828	$0	73,656	D

Explanation of Responses:

1. Common stock acquired on the vesting of Restricted Stock Units.

2. Number of shares withheld for tax purposes.

3. The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

4. The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

5. Restricted Stock Units do not have an expiration date.

6. The Restricted Stock Units identified in this row were granted on January 15, 2024 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

7. The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

8. The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

9. The Restricted Stock Units set forth in this row were granted on January 15, 2026 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

Remarks:

	/s/ Mark C. Hagan	01/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.